Kreutzer, Ulrike, and Thomas Jue. Role of myoglobin as a scavenger of cellular NO in myocardium. Am J Physiol Heart Circ Physiol 286: H985-H991, 2004; 10.1152/ajpheart.00115.2003.-Recent studies have detected a 1 H nuclear magnetic resonance (NMR) reporter signal of metmyoglobin (metMb) during bradykinin stimulation of an isolated mouse heart. The observation has led to the hypothesis that Mb reacts with cellular nitric oxide (NO). However, the hypothesis depends on an unequivocal detection of metMb signals in vivo. In solution, nitrite oxidization of Mb produces a characteristic set of paramagnetically shifted 1 H NMR signals. In the upfield spectral region, MbO2 and MbCO exhibit the ␥CH3 Val E11 signals at Ϫ2.8 and Ϫ2.4 ppm, respectively. In the same spectral region, nitrite oxidation of Mb produces a set of signals at Ϫ3.7 and Ϫ4.7 ppm at 35°C. Previous studies have confirmed the visibility of metMb signals in perfused rat myocardium. With bradykinin infusion, perfusion pressure and rate-pressure product decrease, consistent with endogenous NO formation. However, neither myocardial O2 consumption nor high-energy phosphate levels, as reflected in the 31 P NMR signals, show any significant change. Bradykinin still triggers a similar physiological response even in the presence of CO that is sufficient to inhibit 86% Mb. In all cases, the 1 H NMR spectra from perfused rat myocardium reveal no metMb signals. The results suggest that bradykinin-induced NO does not interact significantly with cellular Mb to produce an NMR-detectable quantity of metMb in the perfused rat myocardium. As a consequence, the experiments cannot confirm the intriguing proposal that Mb acts as a cellular NO scavenger.
nuclear magnetic resonance; heart; oxidative phosphorylation; bioenergetics; respiration THE PRESENCE OF MYOGLOBIN (Mb) in myocytes has always raised questions about its functional role as just a O 2 storage protein or a facilitator of O 2 diffusion (1, 35, 37) . The high concentration of Mb in marine animals certainly buffers tissue hypoxemia during a dive or apnea, but in a beating rat heart, the Mb O 2 store can prolong normal heart function for only a few seconds (4, 13, 26) . Investigators have also posited that Mb facilitates O 2 transport in the cell because the low PO 2 environment regulating cellular function would confer a potential advantage of oxymyoglobin (MbO 2 ) versus free O 2 diffusion (35) . Yet Mb inactivation with CO or nitrite has yielded mixed results. Some experiments have detected an altered metabolic (met) response on Mb inactivation; others, however, have found no significant change in respiration or high-energy phosphate state (6, 12, 32) . Physical measurements under in vivo conditions have yet to confirm definitively that Mb diffusion can compete effectively with free O 2 diffusion (15, 33) . These observations have stimulated researchers to consider other functional roles of Mb.
Recent studies have reported the detection of a metmyoglobin (metMb) reporter signal in perfused isolated mouse hearts during bradykinin stimulation (8) . Because bradykinin stimulates endogenous nitric oxide (NO) production, which can subsequently oxidize Mb, the observation suggests that Mb reacts with cellular NO and acts as an NO scavenger (8) . Such a novel role for Mb has attracted exuberant endorsements and indirectly supports the role of NO in regulating respiration (3, 10, 24) . However, at first glance, both the low cellular level of NO and an active Mb reductase appear to militate against a significant presence of cellular metMb and therefore any nuclear magnetic resonance (NMR)-detectable signals. Clearly, corroborative NMR experiments must confirm the detection of metMb in vivo to underpin the novel NO scavenging role for Mb.
We have investigated the interaction of NO synthesis and Mb oxidation in the well-defined perfused rat heart model. On nitrite oxidation, the characteristic set of metMb signals appears in the 1 H NMR spectra, consistent with previous in vitro and in vivo observations (5, 22) . The upfield reporter metMb signals appear at Ϫ3.7 and Ϫ4.7 ppm at 35°C (5, 22) . These peaks are distinct from the MbO 2 and MbCO signal of the ␥CH 3 Val E11 at Ϫ2.8 and Ϫ2.4 ppm, respectively, and report on the oxidation of the heme Fe (5, 12, 21) . With bradykinin infusion up to 1 M, perfusion pressure and rate pressure product (RPP) decrease, consistent with the formation of cellular NO. However, myocardial O 2 consumption (MV O 2 ) and high-energy phosphate levels, as reflected in the 31 P NMR spectra, show no statistically significant change. Even in the presence of 86% CO, inhibition of Mb bradykinin still elicits a similar physiological response without any corresponding decrease in respiration or high-energy phosphate levels. In all cases, the 1 H NMR spectra reveal no detectable metMb signals. With nitrite infusion, Mb becomes oxidized and reveals the characteristic metMb signals, in perfect agreement with previous studies (5) . The experimental results then suggest that either bradykinin stimulates a negligible amount of NO production in the myocardium or that the steady-state metMb pool does not rise to an NMR-detectable level in the perfused rat myocardium.
MATERIALS AND METHODS
Animal preparation and heart perfusion. The animal care procedures followed the guidelines of the University of California at Davis's institutional animal care review committee. The procedure for rat heart perfusion at 35°C was performed as previously described (4) . Male Sprague-Dawley rats (350-400 g) were anesthetized by an intraperitoneal injection of pentobarbital sodium (65 mg/kg) and heparinized (1,000 U/kg). The heart was quickly isolated and placed in ice-cold buffer solution until aortic cannulation. The heart was then perfused in Langendorff mode with a Krebs-Henseleit buffer containing (in mM) 118 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.8 CaCl2, 23 NaHCO3, 1.2 MgSO 4, and 15 glucose. The perfusate was maintained at 35°C with a circulating water bath (Lauda MT-3) and temperature-jacketed reservoirs and tubings. A peristaltic pump (Rainin Rabbit) maintained a constant, nonrecirculating perfusion flow. Perfusion pressure was measured with a pressure transducer (Medex) via a Y-connection in the aortic cannula. After the heart had stabilized the perfusate flow rate was adjusted to result in a mean perfusion pressure of 87 mmHg, which corresponds to a constant flow rate of ϳ19 ml/min. A salinefilled latex balloon inserted in the left ventricle monitored the heart rate (HR) and left ventricular (LV) pressure via a second pressure transducer. The balloon volume was adjusted to give an end-diastolic pressure of 6-8 mmHg. RPPs were calculated from HR times the LV developed pressure (LVDP). The perfusate was first gassed with 95% O2-5% CO2 and then passed through a home-built oxygenator equilibrated with the desired gas mixture. The oxygenator contained 50 ft of gas-permeable Silastic tubing (0.058 in ID, 0.077 in OD; Dow Corning) wrapped around a heat exchanger. The perfusate was passed through a 5-and 0.45-m Millipore filter. Pressure transducers as well as O 2 electrode were connected to a Biopac recording system.
Perfusate O 2 measurement. Perfusate flowing from the pulmonary artery formed a bath in the NMR tube, in which the heart was placed and was subsquently isolated with a Teflon plug with holes to permit perfusate overflow. Approximately 50% of the perfusate was withdrawn via a Tygon catheter inserted at the level of the pulmonary artery at a constant rate of 10 ml/min. The remaining 50% was withdrawn above the Teflon plug as overflow. The correction was based on parallel experiments with exactly the same perfusion equipment arrangement, experimental conditions, and tubing length, which were employed in the NMR experiments. No heart was connected to the inflow catheter. As the perfusate oxygen tension varied with different mixtures of 95% O2-5% CO2 and 95% N 2-5% CO2, two sets of measurements mapped the O2 at the oxygen electrode and at the catheter tip of the inflow and outflow lines, respectively (n ϭ 6). The sampled data at the oxygen chambers were plotted against the data at the catheter tips, yielding a linear calibration curve for both the inflow (y ϭ 0.92 x ϩ 14, r Ͼ 0.99) and outflow (y ϭ 1.15x Ϫ 24, r Ͼ 0.99), where y ϭ PO2 at the catheter tip and x ϭ PO2 at the chamber. The measured values were corrected according to these calibrations and are designated in the study as the arterial and venous PO2.
MV O2 was calculated then from the arterial and venous oxygen content and the flow rate. For control hearts, the MV O2 was 28.2 ϩ 3.0 mol/min g dry wt (n ϭ 6).
Nitrite oxidation of Mb. A 5/1 stoichiometry of sodium nitrite (Aldrich) to Mb will immediately oxidize all MbO2 to metMb in vitro. The reaction is characterized by the disappearance of the MbO 2 ␣-and ␤-bands at 581 and 543 nm, respectively, and the appearance of the broad metMb bands at 505 and 635 nm (Agilent model 8452A spectrophotometer). Parallel 1 H NMR and perfused heart experiments confirm Mb oxidization under these conditions because the characteristic set of metMb signals appear as MbO2 signals disappear, thereby confirming the conversion of all MbO2 to metMb (5) .
Infusion protocol. After a 20-to 30-min control period, bradykinin was infused through a Y connector in the inflow perfusion to reach 10 Ϫ7 or 10 Ϫ6 M concentration in the arterial perfusate. 1 H and 31 P spectra were acquired during the control, 20-min bradykinin infusion, and the reperfusion period. At the end of the experiment, 40 mM NaNO2 was infused to confirm the detection of the metMb signals (5).
For CO equilibration experiments, a gas flow controller (model 400, Teledyne Hastings) introduced CO into the oxygenator to achieve a final gas mixture of 85% O 2-5% CO2-10% N2 or 10% CO. After the control period, in which the heart was perfused with O 2-saturated buffer, the gas mixture was switched to N2 for 20 min then to CO. After 20 min of CO perfusion, 10 Ϫ7 M bradykinin was infused for 20 min.
NMR. A DRX 400-MHz Bruker spectrometer was used to record 1 H/ 31 P signals with a 20-mm 1 H-{X} probe. A modified 1331 binomial pulse sequence suppressed the H2O line and centered the excitation at Ϫ3.2 ppm, between the MbO2 Val E11 resonance at Ϫ2.8 ppm and the metMb reporter signal at Ϫ3.7 ppm (18, 21). The 1 H 90°p ulse was 70 s, calibrated against the perfusate H2O signal. Observing the MbO2 signal required a 40-ms acquisition time. The spectral width was set at 8,065 Hz; the data size was 512 points. Three thousand transients were averaged for a typical 1 H spectrum, requiring ϳ3 min of signal accumulation. The free induction decays were zero filled to 2K and multiplied by an exponential-Gaussian window function. A spline fit then smoothed the baseline. All spectral lines were referenced as 4.65 ppm at 35°C, which was in turn calibrated against sodium-3-(trimethylsilyl)propionate-2,2,3,3-d4. For the 31 P spectra, a typical control spectrum used a 45°pulse angle, a 0.5-s repetition time, and 256 scans/block (ϳ2.5 min). The 31 P 90°pulse was 72 s, calibrated against a 0.1 M phosphate solution. Spectral width was set at 6,494 Hz; the data size was 4K. Free induction decays were zero-filled to 8K and apodized with an exponential function. The 31 P signals were referenced to phosphocreatine as 0 ppm and integrated to obtain relative concentrations.
1 H NMR spectra of horse heart (Sigma) metMb solutions in D2O were recorded with a 5 mm 1 H[
13 C] probe with a 1 H 90°pulse of 6.5 s using identical 1 H acquisition parameters.
RESULTS

The distinct
1 H NMR signals of solution state metMb are shown in Fig. 1 . Figure 1A shows the upfield spectra of horse heart metMb obtained with a broadband excitation pulse. Four Fig. 1 . Nonselective and selective excitation of 1 H nuclear magnetic resonance (NMR) signals of horse heart metmyoglobin (metMb) in D2O. A: nitrite oxidation of MbO2 to metMb results in the appearance of four metMb signals at Ϫ3.7, Ϫ4.7, Ϫ6.1, and Ϫ7.0 ppm at 35°C. The two temperature-dependent signals at Ϫ3.7 and Ϫ4.7 ppm resonate in the same spectral region where the ␥CH3 Val E11 signal of MbO2 at Ϫ2.8 ppm would appear. B: a semiselective binomial-selective excitation frequency centered at Ϫ3.2 ppm suppresses the water signal and is required for in vivo investigation of perfused myocardium. The excitation selectivity detects clearly the in phase metMb signal at Ϫ3.7 ppm and has sufficient bandwidth to detect the second metMb peak at Ϫ4.7 ppm as well. However, it has insufficient excitation bandwidth to detect the signals at Ϫ6.1 and Ϫ7.0 ppm. distinct upfield signals appear at Ϫ3.7, Ϫ4.7, Ϫ6.1, and at Ϫ7.0 ppm at 35°C. These unassigned signals exhibit a characteristic temperature dependence associated with a paramagnetic interaction and must arise from either the heme groups or amino acid residues interacting with the heme Fe (22) . Specifically, the two metMb reporter signals at Ϫ3.7 and Ϫ4.7 ppm appear in the region where the ␥CH 3 Val E11 signals of MbCO and MbO 2 at Ϫ2.4 and Ϫ2.8 ppm would resonate. With a semiselective excitation centered at Ϫ3.2 ppm, the spectra reveal clearly the metMb signal at Ϫ3.7 and Ϫ4.7 ppm (Fig.  1B ). These two signals serve then to identify the presence of metMb in tissue.
With the perfused heart under normoxic, bradykinin infusion, and reperfusion conditions, the NMR spectra and physiological monitors map the alterations in the Mb oxidation states as well as cellular function. Under control condition, the 1 H NMR spectra show the distinct signal of the Mb Val E11 signal at Ϫ2.8 ppm. The RPP and MV O 2 are consistent with previous reports (see Table 1 ). After a 20-min control period, the heart received 10 Ϫ7 M bradykinin in the arterial perfusate. The physiological response is shown in Fig. 2 . Although the control HR 255 Ϯ 38 shows no significant difference after bradykinin infusion, 262 Ϯ 32 beats/min, the LVDP drops from 118 Ϯ 7 to 100 Ϯ 6 mmHg, which results in a RPP change from 30 Ϯ 4 ϫ 10 3 to 26 Ϯ 3 ϫ 10 3 mmHg/min. The perfusion pressure also decreases from 87 Ϯ 6 to 71 Ϯ 4 mmHg. The decrease in perfusion pressure and RPP mirror the literature reported action of bradykinin, mediated purportedly by NO formation (2, 7, 27) . No perturbation appears in the 31 Figure 3 reveals the bradykinin interaction in the presence of CO. A buffer saturated with 10% N 2 -85% O 2 -5% CO 2 serves as the control condition because the Mb inactivation experiment uses 10% CO saturated buffer to inhibit 86% of Mb. The histograms of perfusion pressure, RPP, and MV O 2 show a small but significant alteration with the infusion of CO to saturate MbCO at 86%. The physiological response is consistent with previous experimental observations (12, 34) . With 86% Mb inactivated by CO, bradykinin still decreases significantly perfusion pressure and RPP. The data are listed in Table 2 . Figure 4 shows the corresponding 1 H NMR spectra of Mb in the presence of bradykinin and CO. Under control conditions, 95% O 2 -5% CO 2 the signal from the Val E11 of Mb is clearly detectable (see Fig. 4A ). On 10 Ϫ7 M bradykinin infusion, the spectra display no spectral change in the peak from MbO 2 . No metMb signals appear (see Fig. 4B ). Even with 10 Ϫ6 M infused bradykinin, no metMb signal appears. Figure 4C shows the spectra after introduction of a gas mixture of 85%O 2 -10% CO-5% CO 2 and bradykinin. The MbCO peak at Ϫ2.4 ppm emerges. Bradykinin does not affect either the MbCO or the residual MbO 2 Val E11 signal and still does not produce any metMb signal. After reperfusion with oxygenated buffer to remove the CO and to restore fully the MbO 2 peak, a perfusion with 40 mM nitrite buffer induces Mb oxidation to produce the characteristic metMb signals at Ϫ3.7 and Ϫ4.7 ppm (Fig. 4D) .
DISCUSSION
Bradykinin-induced oxidation of Mb. Recent studies (8) have observed the presence of a metMb signal on bradykinin stimulation of perfused mouse heart and have ascribed a novel NO-mediated Fe(II) to Fe(III) oxidation of cellular Mb. The observation has led to a newly proposed role for Mb as an NO scavenger, which has generated much exuberance (3). In the solution state, the oxidation of MbO 2 to metMb produces a characteristic spectral change in the upfield region. In partic- Values are means Ϯ SD; n ϭ 6 hearts (n ϭ 5, PCr/ATP). LVDP, left ventricular developed pressure; HR, heart rate; PP, perfusion pressure; MV O2, O2 consumption; MbO2, oxymyoglobin; PCr/ATP, phosphocreatine-to-ATP ratio. *P Ͻ 0.05, significant difference vs. control. ular, two reporter signals at Ϫ3.7 and Ϫ4.7 ppm 35°C identify the presence of metMb (Fig. 1 ). Solutions studies (22) have not assigned these peaks, which do not originate from any heme group. Integration analysis shows that the peaks correspond to the three-proton intensity. However, the line width of the metMb signal at Ϫ3.7 ppm is 60% broader than the Val E11 signal of MbO 2 at Ϫ2.8 ppm (5).
Even with selective excitation, both metMb reporter signals at Ϫ3.7 and Ϫ4.7 ppm must appear in the spectra, consistent with previous experimental findings (5, 22) . Figure 1 illustrates the upfield spectral region of MbO 2 and metMb, obtained from broadband and selective excitation. In response to bradykinin stimulation, the cell produces NO, which triggers vasodilation, as reflected in the perfusion pressure and LVDP. Indeed, bradykinin elicits a significant drop in perfusion pressure (from 87 to 71 mmHg) and in RPP (30 to 26 mmHg/min) and LVDP (from 118 to 100 mmHg). HR remains unchanged (255 and 262 min Ϫ1 ). However, no significant concomitant decrease in MV O 2 occurs. Infusing bradykinin at the physiological 10
Ϫ7 M dosage appears to saturate the cell receptors. Increasing stepwise the bradykinin concentration from 10 Ϫ7 to 10 Ϫ6 M produces no dose-dependent alteration in the physiological response. The observation is consistent with NO production, as described in previous reports (8, 16, 25) .
Despite the presence of NO, the observed 1 H NMR spectra from perfused rat myocardium do not reveal any metMb signals, even when the heart receives the pharmacological dose of 10 Ϫ6 M bradykinin. An infusion of nitrite to oxidize cellular Mb confirms that the NMR has the sensitivity to detect the metMb signals, consistent with previous observations (22) . Clearly, in perfused rat myocardium the experimental data do not show any significant interaction of Mb with NO to produce a detectable amount of metMb. Given the 15/1 signal to noise (S/N) of the Val E11 Mb signal at Ϫ2.8 ppm, corresponding to ϳ200 M Mb, the NMR technique has the threshold sensitivity to detect a 10% saturated MbO 2 (2/1 S/N) and can quantitatively evaluate changes in 20% MbO 2 (4/1 S/N) However, the paramagnetic relaxation of metMb broadens the Ϫ3.7 ppm peak line by 60%, relative to Val E11 signal. Consequently, a completely oxidized cellular metMb of 200 M will yield only a 9/1 S/N. A threshold detectable limit of 2/1 S/N will require the presence of at least 20% metMb or 40 M, whereas a quantitative analysis will require 40% metMb or 80 M.
Detectability of NO interaction with Mb. In light of the experimental results of this study, the feasibility of detecting an NO-induced metMb signal in myocardium requires a reexamination. The cellular NO concentration depends on the net NO formation and degradation kinetics, such as the NO synthase (NOS) and Mb reductase reactions. Although much uncertainty still surrounds the parameters required to conduct a rigorous kinetics analysis, in vitro data still yield an estimate of the steady-state concentration of NO to produce an NMR detectable metMb signal and the time required to reach a particular steady-state concentration.
The analysis depends on an ideal limiting case: no Mb reductase activity and NO degradation pathways exist. The steady state approximates the equilibrium state, which seems reasonable in light of the rapid kinetics of Mb binding to O 2 and NO and the subsequent oxidation of Mb to metMb. The cellular Mb is 200 M and is completely NMR visible (14, 17) . Finally, the basal O 2 concentration is Ͼ10 M (19, 20) . The O 2 concentration assumption arises from perfused or in situ rat myocardium experiments, where NMR has the sensitivity to measure 10% deoxy Mb and yet cannot detect the proximal hisitdyl NH signal of deoxy Mb signals under normoxic conditions. That suggests the myocyte basal cellular PO 2 saturates Ͼ90% of the MbO 2 or a cellular PO 2 threshold concentration of ϳ10 M, given the Mb p 50 of 2.4 Torr (3.2 M) at 37°C (4, 18, 19, 28) . In vitro kinetics studies show that NO binds to Mb with ϳ230,000 times higher affinity than O 2 at a dissociation constant (K D NO/K D O 2 ϭ 4 ϫ 10 Ϫ6 M/9 ϫ 10 Ϫ1 M), Table  3 (11, 28) . Given the resting O 2 concentration as 10 M, the NO concentration associated with a 1/1 ratio of MbNO/MbO 2 is then 10 M/2.3 ϫ 10 5 ϭ 4.3 ϫ 10 Ϫ5 M. If all of the MbNO reacts to produce the end product metMb, then the required NO is also 4.3 ϫ 10 Ϫ5 M. To produce a threshold detectable signal, reflecting 20% metMb or metMb/MbO 2 at 1/4 ratio, requires an equilibrated, free steady-state NO concentration of 8 ϫ 10 Ϫ6 M. During bradykinin stimulation, local NO levels can rise to 8 ϫ 10 Ϫ1 M (23). However, the cellular MbO 2 concentration is 200 M, and a 1/1 mixture would mean that 100 M of Mb must exist as either MbNO or MbO 2 . Because NOS is the only source of NO formation in the cell, it must synthesize at least 100 M of NO to bind Mb and then maintain a free NO concentration at 4.3 ϫ 10 Ϫ5 M to reach metMb/MbO 2 at a 1:1 ratio. Malinski and colleagues (23) used a microsensor technique to determine the bradykinin-induced NO formation rate. They reported a NO formation rate of 0.04 M/s in rabbit aorta at 100 m distance from an endothelial cell (23) . Assuming this NO formation rate with no competing degradation reaction, the cell NO kinetics will require 2,500 s or 42 min for NO to reach a steady-state level, sufficient to produce 100 M of MbNO. Even at the NO concentration required to achieve the threshold detection 1:4 ratio of metMb/MbO 2 , the reaction requires 1,000 s or 17 min.
In the cell, the ideal limiting conditions of the analysis certainly do not hold. NO oxidation of Mb must take much longer because many reactions compete against the formation of steady-state NO and metMb: NO has a very short half-life and reacts via other metabolic pathways. Mb reductase reduces metMb at a rate of 0.5 M/s, 10 times faster than the NO production rate (see Table 3 ) (26) . Finally, NO reacts with Mb in a complex set of reactions: it can react with Fe(II) as well as Fe(III) Mb and involves different reaction intermediates, which argue against a simple interpretation of NO reaction with Mb in vivo (9) .
Although the above analysis has several uncertainties and will require further experimental data on NO production, Mb reductase activity, and local NO level to substantiate, the competing enzyme reactions in the cell and the NO formation time to oxidize Mb to metMb would tend to militate against an NMR-detectable concentration of metMb in the cell, consistent with the results reported in this present study.
CO and NO interaction. If NO reacts significantly with cellular Mb to produce metMb, then introducing CO into the perfusate to inhibit Mb function might mask the Mb function as an NO scavenger (3, 12) . The extent of the interference depends upon the cellular NO concentration. In perfused rat heart studies, CO can inactivate Mb without altering respiration, when the MbCO/MbO 2 ratio is Ͻ4/1 (12). Given the cellular O 2 concentration of ϳ10 M and the MbCO/MbO 2 partition coefficient of 36, the cell must contain 1.1 M CO to achieve a MbCO/MbO 2 ratio of 4/1. If the cell can attain a steady state, 1.1 ϫ 10 Ϫ4 M of NO in the presence of 1.1 M CO the MbNO/MbCO will reach a 1:1 ratio, based on the MbCO/MbNO partition coefficient of 9,000 (11, 34) . Table 3 shows that the cellular NO concentration can reach 10 Ϫ2 M, which would yield an MbNO/MbCO ratio of 82/1. In effect, the presence of sufficient CO to inhibit 80% of Mb function but not respiration does not appear to significantly impair any imputed NO scavenging function of Mb, if NO reaches 10 Ϫ2 M. However, if NO does not reach that level, CO can 1 H NMR spectra of isolated rat heart perfused with 95% O2-5% CO2 (A), 95% O2-5% CO2 and 10 Ϫ7 M bradykinin (B), 85% O2-5% CO2-10% CO and 10 Ϫ7 M bradykinin (C), and 95% O2-5% CO2 and 40 mM nitrite (D). Under normoxic conditions, the Mb ␥CH3 Val E11 signal appears at Ϫ2.8 ppm, reflecting the control myocardial oxygenated state. With bradykinin, the physiological response is consistent with nitric oxide (NO) production. However, no changes appear in the 1 H spectra. With 10% CO, the CO displaces the MbO2 and saturates 86% of the Mb. Bradykinin infusion still produces an NO-induced change in the physiological response. However, the ␥CH3 Val E11 MbCO signal at Ϫ2.4 ppm remains constant. On reperfusion with 95% O2-5% CO2 and 40 mM nitrite, nitrite oxidizes Mb to metMb, revealing the two characteristic peaks at Ϫ3.7 and 4.7 ppm.
certainly affect Mb scavenging of NO. However, that condition would raise the other perspective in the present analysis: bradykinin cannot induce sufficient NO to form a detectable metMb signal. Any purported role of Mb in NO scavenging becomes moot.
The potential CO interference with Mb function as a postulated NO scavenger has led some investigators to dismiss peremptorily the validity of any CO inactivation experiments to assess Mb function (3) . That perspective, however, overlooks the published data consistent with present study's results. CO inactivation of Mb does not produce any significant functional or MV O 2 degradation over a broad range of physiological conditions in the rat myocardium, including ischemia and postischemic reperfusion (12, and Y. Chung, S. J. Huang, and A. Glabe, unpublished observations). The initial decline in the myocardial RPP with very low CO concentration appears to originate from the direct CO binding to guanylate cyclase rather than any binding with myoglobin. Neither RPP nor MV O 2 shows a dose-dependent relationship with CO until MbCO saturation Ͼ75% (12). The observation is consistent with the observation that O 2 has a higher binding affinity to cytochrome oxidase than CO (36) .
If as asserted, MbCO can no longer scavenge NO, then NO would bind to cytochrome oxidase and reduce the respiration rate, according to the paradigm of NO regulation of respiration (10, 24) . Yet, up to 86% Mb inhibition with CO in perfused rat myocardium, MV O 2 remains constant (12) . In the presence of CO inactivation of Mb, bradykinin, however, still exerts the identical physiological alteration associated with NO formation. Although exogenous CO inactivates 86% of Mb, neither CO nor MbCO impairs the bradykinin-induced myocardial and vascular response to NO. The results are consistent with the view that CO inhibition of Mb does not appear to modulate any NO interaction with cytochrome oxidase, resulting in a decrease in respiration. Alternatively, Mb does not participate significantly in scavenging cellular NO in the perfused myocardium, consistent with the current study's experimental results.
NO modulation of respiration. A respiratory control model has recently emerged to posit a role of NO in modulating mitochondrial energy generation (10, 24) . In that model, the competitive binding of NO and O 2 serves to regulate cytochrome oxidase activity and therefore energy generation. Clearly, if Mb binds NO, it would modulate the available NO/O 2 ratio and could control respiration (8) . However, the present study has not detected any metMb signal during bradykinin stimulation, although the physiological response indicates the presence of NO. In the presence of exogenous CO sufficient to saturate 86% of Mb, bradykinin still elicits the NO-induced response. The undetected metMb signals under well oxygenated as well as under CO inactivation conditions imply that Mb does not appear to interact significantly with NO. In conclusion, under the reported experimental conditions, the results have not confirmed the findings of Flogel et al. (12) and therefore the hypothesis that Mb functions as a bioscavenger of NO.
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